Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma.
Katelyn StepanEthan CraigScott Andrew SkillingtonBrian C DeutschStephanie Y ChenNneoma S WamkpahCraig A BolligDorina KallogjeriWade L ThorstadSidharth V PuramPatrik PipkornRyan S JacksonPublished in: Head & neck (2022)
The rate of SPM among patients with HPV-positive OPSCC is lower than reported rates among HPV-negative OPSCC. To date, this is the largest study evaluating SPM in patients with surgically treated HPV-positive OPSCC.